ฉันรักการ As a substrate of CYP 3A4

ฉันรักการ As a substrate of CYP 3A4, dolutegravir is affected by rifampin, efavirenz, tipranavir/ritonavir, fosamprenavir/ritonavir, and dose increase is required. Dolutegravir inhibits the organic cation transporter 2, resulting in decreased creatinine clearance with no apparent decrease in renal function. Other adverse effects are minimal but include diarrhea, headache, and nauseaแปล

ผลลัพธ์ (อังกฤษ) 1:

I love As a substrate of CYP 3A4, dolutegravir is affected by tipranavir/ritonavir, efavirenz, rifampin, fosamprenavir/ritonavir dose increase is required, and inhibits the organic cation transporter Dolutegravir. 2, resulting in decreased creatinine clearance decrease in renal function with no apparent adverse effects are minimal but Other 3270 include diarrhea, headache, nausea and translations.

ผลลัพธ์ (อังกฤษ) 2:

I love As a substrate of CYP 3A4, dolutegravir is affected by rifampin, efavirenz, tipranavir / ritonavir, fosamprenavir / ritonavir, and dose increase is required. Dolutegravir inhibits the organic cation transporter 2, resulting in decreased creatinine clearance with no apparent decrease in. renal function. Other adverse effects are minimal but include diarrhea, headache, and nausea Translate.

ผลลัพธ์ (อังกฤษ) 3:

I love to As a substrate of CYP 3A4 dolutegravir is, affected by rifampin efavirenz tipranavir / ritonavir,,,, fosamprenavir / ritonavir. And dose increase is required. Dolutegravir inhibits the organic cation transporter 2 resulting in, decreased creatinine. Clearance with no apparent decrease in renal function. Other adverse effects are minimal but include diarrhea headache,,And nausea translation.